A post hoc analysis of a study investigating drugs containing semaglutide, such as Ozempic and Wegovy, in those living with HIV, suggests that the GLP-1 drugs may help slow biological aging.
Continue reading at Medical News Today.

A post hoc analysis of a study investigating drugs containing semaglutide, such as Ozempic and Wegovy, in those living with HIV, suggests that the GLP-1 drugs may help slow biological aging.
Continue reading at Medical News Today.